{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:04:56Z","timestamp":1791396296160,"version":"4.3.3"},"reference-count":181,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.drup.2008.08.002","type":"journal-article","created":{"date-parts":[[2008,9,25]],"date-time":"2008-09-25T08:47:57Z","timestamp":1222332477000},"page":"164-179","source":"Crossref","is-referenced-by-count":255,"title":["Mechanisms of proteasome inhibitor action and resistance in cancer"],"prefix":"10.1016","volume":"11","author":[{"given":"David J.","family":"McConkey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2008.08.002_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1634\/theoncologist.7-1-9","article-title":"Development of the proteasome inhibitor PS-341","volume":"7","author":"Adams","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.drup.2008.08.002_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1535-6108(04)00120-5","article-title":"The development of proteasome inhibitors as anticancer drugs","volume":"5","author":"Adams","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib3","first-page":"2615","article-title":"Proteasome inhibitors: a novel class of potent and effective antitumor agents","volume":"59","author":"Adams","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/0008-5472.CAN-06-1567","article-title":"Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma","volume":"67","author":"Aghdassi","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib5","doi-asserted-by":"crossref","first-page":"7896","DOI":"10.1158\/0008-5472.CAN-05-0506","article-title":"Effects of PS-341 on the activity and composition of proteasomes in multiple myeloma cells","volume":"65","author":"Altun","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1158\/1535-7163.MCT-06-0255","article-title":"Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib","volume":"6","author":"An","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2008.08.002_bib7","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1182\/blood-2006-03-012542","article-title":"CD28-mediated regulation of multiple myeloma cell proliferation and survival","volume":"109","author":"Bahlis","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.drup.2008.08.002_bib8","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.274.5288.782","article-title":"An essential role for NF-kappaB in preventing TNF-alpha-induced cell death","volume":"274","author":"Beg","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.drup.2008.08.002_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.molcel.2004.12.021","article-title":"Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation","volume":"17","author":"Bennett","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib10","first-page":"805","article-title":"Cellular mechanisms of protein quality control","volume":"46","author":"Bennett","year":"2006","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.drup.2008.08.002_bib11","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1158\/0008-5472.CAN-06-2722","article-title":"Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors","volume":"67","author":"Birle","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib12","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1158\/1078-0432.CCR-03-0781","article-title":"Approval summary for bortezomib for injection in the treatment of multiple myeloma","volume":"10","author":"Bross","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/cncr.23224","article-title":"Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits","volume":"112","author":"Busse","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.drup.2008.08.002_bib14","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1158\/1535-7163.MCT-05-0437","article-title":"Bortezomib inhibits docetaxel-induced apoptosis via a p21-dependent mechanism in human prostate cancer cells","volume":"5","author":"Canfield","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2008.08.002_bib15","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","article-title":"New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathway","volume":"96","author":"Cantley","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2008.08.002_bib16","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/jcp.21444","article-title":"Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells","volume":"216","author":"Cascone","year":"2008","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.drup.2008.08.002_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1078-0432.CCR-05-2272","article-title":"Velcade and vitamin C: too much of a good thing?","volume":"12","author":"Catley","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccr.2005.10.013","article-title":"A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from bortezomib","volume":"8","author":"Chauhan","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.bjc.6603406","article-title":"A novel proteasome inhibitor NPI-0052 as an anticancer therapy","volume":"95","author":"Chauhan","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2008.08.002_bib20","first-page":"6174","article-title":"Blockade of Hsp27 overcomes Bortezomib\/proteasome inhibitor PS-341 resistance in lymphoma cells","volume":"63","author":"Chauhan","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib21","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood-2007-08-105601","article-title":"Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma","volume":"111","author":"Chauhan","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.drup.2008.08.002_bib22","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1038\/sj.onc.1210028","article-title":"A novel Bcl-2\/Bcl-X(L)\/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma","volume":"26","author":"Chauhan","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2008.08.002_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","article-title":"Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function","volume":"17","author":"Chen","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib24","first-page":"3535","article-title":"Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition","volume":"61","author":"Cusack","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib25","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1038\/sj.onc.1206863","article-title":"Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK\/JNK- and NF-kappaB-dependent process","volume":"22","author":"Dai","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2008.08.002_bib26","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2006-11-053728","article-title":"Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells","volume":"110","author":"Davenport","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.drup.2008.08.002_bib27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4161\/cc.7.7.5615","article-title":"Untangling the unfolded protein response","volume":"7","author":"Davenport","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.drup.2008.08.002_bib28","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bcp.2006.08.007","article-title":"The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development","volume":"72","author":"Dejardin","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drup.2008.08.002_bib29","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1158\/0008-5472.CAN-06-4086","article-title":"Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome","volume":"67","author":"Demo","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib30","doi-asserted-by":"crossref","first-page":"10161","DOI":"10.1128\/MCB.24.23.10161-10168.2004","article-title":"Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2","volume":"24","author":"Deng","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.drup.2008.08.002_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4161\/auto.5190","article-title":"Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome","volume":"4","author":"Ding","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2008.08.002_bib32","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1074\/jbc.M609267200","article-title":"Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival","volume":"282","author":"Ding","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2008.08.002_bib33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2353\/ajpath.2007.070188","article-title":"Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability","volume":"171","author":"Ding","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.drup.2008.08.002_bib34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1073\/pnas.94.3.855","article-title":"Activation of the cell death program by inhibition of proteasome function","volume":"94","author":"Drexler","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2008.08.002_bib35","first-page":"163","article-title":"Assays for proteasome inhibition","volume":"85","author":"Elliott","year":"2003","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.drup.2008.08.002_bib36","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0955-0674(95)80066-2","article-title":"Apoptosis and the cell cycle","volume":"7","author":"Evan","year":"1995","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.drup.2008.08.002_bib37","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.2741\/2926","article-title":"Oxidative stress in neurodegeneration and available means of protection","volume":"13","author":"Fatokun","year":"2008","journal-title":"Front Biosci."},{"key":"10.1016\/j.drup.2008.08.002_bib38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/anie.200390115","article-title":"Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora","volume":"42","author":"Feling","year":"2003","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.drup.2008.08.002_bib39","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.1158\/0008-5472.CAN-05-0686","article-title":"Differential regulation of Noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications","volume":"65","author":"Fernandez","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9440(10)62994-X","article-title":"Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers","volume":"167","author":"Fratta","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.drup.2008.08.002_bib41","doi-asserted-by":"crossref","first-page":"9695","DOI":"10.1128\/MCB.24.22.9695-9704.2004","article-title":"Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells","volume":"24","author":"Fribley","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.drup.2008.08.002_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jcb.21405","article-title":"Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells","volume":"103","author":"Fuchs","year":"2008","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.drup.2008.08.002_bib43","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.295.5555.612","article-title":"Cancer research. Taking garbage in, tossing cancer out?","volume":"295","author":"Garber","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.drup.2008.08.002_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1042\/BST0350012","article-title":"Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy","volume":"35","author":"Goldberg","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.drup.2008.08.002_bib45","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1101\/gad.13.15.1899","article-title":"BCL-2 family members and the mitochondria in apoptosis","volume":"13","author":"Gross","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.drup.2008.08.002_bib46","first-page":"6750","article-title":"K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression","volume":"60","author":"Guerrero","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib47","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","article-title":"Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment","volume":"18","author":"Halliwell","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.drup.2008.08.002_bib48","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature04724","article-title":"Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice","volume":"441","author":"Hara","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.drup.2008.08.002_bib49","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1097-2765(00)00108-8","article-title":"Regulated translation initiation controls stress-induced gene expression in mammalian cells","volume":"6","author":"Harding","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/16729","article-title":"Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase","volume":"397","author":"Harding","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.drup.2008.08.002_bib51","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1158\/1078-0432.CCR-05-2305","article-title":"Intracellular protein degradation and its therapeutic implications","volume":"11","author":"Hideshima","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib52","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.1073\/pnas.0503221102","article-title":"Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma","volume":"102","author":"Hideshima","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2008.08.002_bib53","doi-asserted-by":"crossref","first-page":"16639","DOI":"10.1074\/jbc.M200360200","article-title":"NF-kappa B as a therapeutic target in multiple myeloma","volume":"277","author":"Hideshima","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2008.08.002_bib54","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1182\/blood-2002-08-2543","article-title":"Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341","volume":"101","author":"Hideshima","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.drup.2008.08.002_bib55","doi-asserted-by":"crossref","first-page":"8766","DOI":"10.1038\/sj.onc.1208118","article-title":"p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells","volume":"23","author":"Hideshima","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2008.08.002_bib56","first-page":"3071","article-title":"The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells","volume":"61","author":"Hideshima","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1247\/csf.15.393","article-title":"Flavonoids inhibit the expression of heat shock proteins","volume":"15","author":"Hosokawa","year":"1990","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.drup.2008.08.002_bib58","first-page":"2969","article-title":"Progression model for pancreatic cancer","volume":"6","author":"Hruban","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib59","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0002-9440(10)65054-7","article-title":"Genetic progression in the pancreatic ducts","volume":"156","author":"Hruban","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.drup.2008.08.002_bib60","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1158\/0008-5472.CAN-07-1015","article-title":"Proteasome function is required for DNA damage response and fanconi anemia pathway activation","volume":"67","author":"Jacquemont","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib61","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1074\/jbc.M413660200","article-title":"Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition","volume":"280","author":"Jiang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2008.08.002_bib62","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1083\/jcb.143.7.1883","article-title":"Aggresomes: a cellular response to misfolded proteins","volume":"143","author":"Johnston","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.drup.2008.08.002_bib63","doi-asserted-by":"crossref","first-page":"30524","DOI":"10.1074\/jbc.M603337200","article-title":"Degradation of amyotrophic lateral sclerosis-linked mutant Cu,Zn-superoxide dismutase proteins by macroautophagy and the proteasome","volume":"281","author":"Kabuta","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2008.08.002_bib64","doi-asserted-by":"crossref","first-page":"15240","DOI":"10.1074\/jbc.M312497200","article-title":"Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide","volume":"279","author":"Kalivendi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2008.08.002_bib65","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1128\/MCB.00552-06","article-title":"Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1alpha C-terminal activation domain","volume":"26","author":"Kaluz","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.drup.2008.08.002_bib66","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1172\/JCI0216886","article-title":"Orchestrating the unfolded protein response in health and disease","volume":"110","author":"Kaufman","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drup.2008.08.002_bib67","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","article-title":"The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress","volume":"115","author":"Kawaguchi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib68","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","article-title":"Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma","volume":"12","author":"Keats","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib69","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/00004647-200010000-00008","article-title":"Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury","volume":"20","author":"Keller","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.drup.2008.08.002_bib70","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1158\/1535-7163.MCT-06-0075","article-title":"Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells","volume":"5","author":"Khanbolooki","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2008.08.002_bib71","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jnr.10298","article-title":"Effect of geranylgeranylaceton on cellular damage induced by proteasome inhibition in cultured spinal neurons","volume":"69","author":"Kikuchi","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.drup.2008.08.002_bib72","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.coi.2003.11.004","article-title":"Proteasome and peptidase function in MHC-class-I-mediated antigen presentation","volume":"16","author":"Kloetzel","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.drup.2008.08.002_bib73","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nature04723","article-title":"Loss of autophagy in the central nervous system causes neurodegeneration in mice","volume":"441","author":"Komatsu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.drup.2008.08.002_bib74","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1083\/jcb.200412022","article-title":"Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice","volume":"169","author":"Komatsu","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.drup.2008.08.002_bib75","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0962-8924(00)01852-3","article-title":"Aggresomes, inclusion bodies and protein aggregation","volume":"10","author":"Kopito","year":"2000","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.drup.2008.08.002_bib76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/embo-reports\/kvd052","article-title":"Aggresomes and Russell bodies. Symptoms of cellular indigestion?","volume":"1","author":"Kopito","year":"2000","journal-title":"EMBO Rep."},{"key":"10.1016\/j.drup.2008.08.002_bib77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/156652408783769599","article-title":"Regulation of Bcl-2 family proteins by posttranslational modifications","volume":"8","author":"Kutuk","year":"2008","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.drup.2008.08.002_bib78","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.drup.2006.11.001","article-title":"The proteasome as a potential target for novel anticancer drugs and chemosensitizers","volume":"9","author":"Landis-Piwowar","year":"2006","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2008.08.002_bib79","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1038\/sj.emboj.7600903","article-title":"XBP-1 is required for biogenesis of cellular secretory machinery of exocrine glands","volume":"24","author":"Lee","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.drup.2008.08.002_bib80","doi-asserted-by":"crossref","first-page":"9946","DOI":"10.1073\/pnas.1334037100","article-title":"Proteasome inhibitors disrupt the unfolded protein response in myeloma cells","volume":"100","author":"Lee","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2008.08.002_bib81","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1034\/j.1600-0463.2003.1110602.x","article-title":"Mutational analysis of Noxa gene in human cancers","volume":"111","author":"Lee","year":"2003","journal-title":"APMIS"},{"key":"10.1016\/j.drup.2008.08.002_bib82","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1535-6108(02)00127-7","article-title":"Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics","volume":"2","author":"Letai","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib83","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1172\/JCI26390","article-title":"Autophagy in cell death: an innocent convict?","volume":"115","author":"Levine","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drup.2008.08.002_bib84","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/46.5.673","article-title":"Proteasome inhibition measurements: clinical application","volume":"46","author":"Lightcap","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.drup.2008.08.002_bib85","doi-asserted-by":"crossref","first-page":"33714","DOI":"10.1074\/jbc.M302559200","article-title":"Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells","volume":"278","author":"Ling","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2008.08.002_bib86","doi-asserted-by":"crossref","first-page":"24881","DOI":"10.1074\/jbc.M004454200","article-title":"Ligand-independent dimerization activates the stress response kinases IRE1 and PERK in the lumen of the endoplasmic reticulum","volume":"275","author":"Liu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2008.08.002_bib87","doi-asserted-by":"crossref","first-page":"18346","DOI":"10.1074\/jbc.M112454200","article-title":"The protein kinase\/endoribonuclease IRE1alpha that signals the unfolded protein response has a luminal N-terminal ligand-independent dimerization domain","volume":"277","author":"Liu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2008.08.002_bib88","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","article-title":"p53-dependent apoptosis modulates the cytotoxicity of anticancer agents","volume":"74","author":"Lowe","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib89","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1124\/jpet.108.138131","article-title":"Point mutation of the proteasome \u03b25 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variant of Jurkat T cell lymphoblastic lymphoma\/leukemia line","volume":"326","author":"L\u00fc","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drup.2008.08.002_bib90","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/sj.onc.1203597","article-title":"PIK3CA as an oncogene in cervical cancer","volume":"19","author":"Ma","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2008.08.002_bib91","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.drup.2006.07.002","article-title":"Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies","volume":"9","author":"Magagnin","year":"2006","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2008.08.002_bib92","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1126\/science.278.5344.1812","article-title":"Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras","volume":"278","author":"Mayo","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.drup.2008.08.002_bib93","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/MCB.21.4.1249-1259.2001","article-title":"Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state","volume":"21","author":"McCullough","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.drup.2008.08.002_bib94","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-06-2258","article-title":"Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition","volume":"67","author":"Meister","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib95","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood-2006-06-026500","article-title":"Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas","volume":"109","author":"Mestre-Escorihuela","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.drup.2008.08.002_bib96","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood-2006-03-013128","article-title":"NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells","volume":"110","author":"Miller","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.drup.2008.08.002_bib97","unstructured":"Miller, R.L., James-Kracke, M., Sun, G.Y., Sun, A.Y., in press. Oxidative and inflammatory pathways in Parkinson's disease. Neurochem. Res."},{"key":"10.1016\/j.drup.2008.08.002_bib98","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1158\/1535-7163.551.3.5","article-title":"Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity","volume":"3","author":"Mimnaugh","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2008.08.002_bib99","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2005-03-1158","article-title":"Antimyeloma activity of heat shock protein-90 inhibition","volume":"107","author":"Mitsiades","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.drup.2008.08.002_bib100","doi-asserted-by":"crossref","first-page":"14374","DOI":"10.1073\/pnas.202445099","article-title":"Molecular sequelae of proteasome inhibition in human multiple myeloma cells","volume":"99","author":"Mitsiades","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2008.08.002_bib101","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.nutr.27.061406.093749","article-title":"Protein turnover via autophagy: implications for metabolism","volume":"27","author":"Mizushima","year":"2007","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.drup.2008.08.002_bib102","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.drup.2008.08.002_bib103","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1182\/blood-2006-10-054577","article-title":"Ghobrial, protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenstrom macroglobulinemia","volume":"109","author":"Moreau","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.drup.2008.08.002_bib104","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drup.2007.05.001","article-title":"Autophagy signalling in cancer and its potential as a novel target to improve anticancer therapy","volume":"10","author":"Moretti","year":"2007","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2008.08.002_bib105","first-page":"1243","article-title":"Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts","volume":"1","author":"Nawrocki","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2008.08.002_bib106","doi-asserted-by":"crossref","first-page":"11510","DOI":"10.1158\/0008-5472.CAN-05-2394","article-title":"Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells","volume":"65","author":"Nawrocki","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib107","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1182\/blood-2007-12-130823","article-title":"Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA","volume":"112","author":"Nawrocki","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.drup.2008.08.002_bib108","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1158\/0008-5472.CAN-05-2370","article-title":"Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis","volume":"65","author":"Nawrocki","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib109","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1158\/0008-5472.CAN-05-2961","article-title":"Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells","volume":"66","author":"Nawrocki","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1158\/1535-7163.59.3.1","article-title":"The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts","volume":"3","author":"Nawrocki","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2008.08.002_bib111","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2141.2008.07066.x","article-title":"Redox homeostasis modulates the sensitivity of myeloma cells to bortezomib","volume":"141","author":"Nerini-Molteni","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drup.2008.08.002_bib112","doi-asserted-by":"crossref","first-page":"19512","DOI":"10.1073\/pnas.0709443104","article-title":"Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis","volume":"104","author":"Nguyen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2008.08.002_bib113","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccr.2008.05.016","article-title":"Argyrin A reveals a critical role for the tumor suppressor protein p27kip1 in mediating anti-tumor activities in response to proteasome inhibition","volume":"14","author":"Nickeleit","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib114","doi-asserted-by":"crossref","first-page":"19488","DOI":"10.1073\/pnas.0708380104","article-title":"Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition","volume":"104","author":"Nikiforov","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2008.08.002_bib115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1158\/1535-7163.MCT-04-0260","article-title":"The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim","volume":"4","author":"Nikrad","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2008.08.002_bib116","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells","volume":"107","author":"Obeng","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.drup.2008.08.002_bib117","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2007-08-104950","article-title":"Molecular basis of bortezomib\/Velcade\u00ae resistance: proteasome subunit \u03b25 (PSMB5) gene mutation and overexpression of PSMB5 protein","volume":"112","author":"Oerlemans","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.drup.2008.08.002_bib118","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.humpath.2006.09.014","article-title":"Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B\/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype","volume":"38","author":"Ogino","year":"2007","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.drup.2008.08.002_bib119","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.drup.2008.08.002_bib120","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/B:APPT.0000045801.15585.dd","article-title":"PI3K-Akt pathway: its functions and alterations in human cancer","volume":"9","author":"Osaki","year":"2004","journal-title":"Apoptosis"},{"key":"10.1016\/j.drup.2008.08.002_bib121","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1172\/JCI0214550","article-title":"Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes","volume":"109","author":"Oyadomari","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drup.2008.08.002_bib122","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nature05853","article-title":"HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS","volume":"447","author":"Pandey","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.drup.2008.08.002_bib123","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1182\/blood-2007-12-130781","article-title":"The BH3-only mimetic ABT-737 synergizes the anti-neoplastic activity of proteasome inhibitors in lymphoid malignancies","volume":"112","author":"Paoluzzi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.drup.2008.08.002_bib124","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1200\/JCO.2004.02.106","article-title":"Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer","volume":"22","author":"Papandreou","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2008.08.002_bib125","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1158\/0008-5472.CAN-03-2707","article-title":"Bortezomib as a potential treatment for prostate cancer","volume":"64","author":"Papandreou","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib126","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.onc.1210679","article-title":"A pivotal role for Mcl-1 in Bortezomib-induced apoptosis","volume":"27","author":"Podar","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2008.08.002_bib127","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1097-2765(00)80456-6","article-title":"The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex","volume":"3","author":"Puthalakath","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib128","doi-asserted-by":"crossref","first-page":"9636","DOI":"10.1158\/0008-5472.CAN-06-0747","article-title":"Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA","volume":"66","author":"Qin","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib129","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1158\/0008-5472.CAN-05-0676","article-title":"Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells","volume":"65","author":"Qin","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1101\/gad.14.2.152","article-title":"An essential role in liver development for transcription factor XBP-1","volume":"14","author":"Reimold","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.drup.2008.08.002_bib131","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/35085509","article-title":"Plasma cell differentiation requires the transcription factor XBP-1","volume":"412","author":"Reimold","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.drup.2008.08.002_bib132","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa030288","article-title":"A phase 2 study of bortezomib in relapsed, refractory myeloma","volume":"348","author":"Richardson","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.drup.2008.08.002_bib133","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa043445","article-title":"Bortezomib or high-dose dexamethasone for relapsed multiple myeloma","volume":"352","author":"Richardson","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.drup.2008.08.002_bib134","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI0216784","article-title":"Translational control in the endoplasmic reticulum stress response","volume":"110","author":"Ron","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drup.2008.08.002_bib135","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1158\/1535-7163.MCT-06-0066","article-title":"The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia (CLL)","volume":"5","author":"Ruiz","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2008.08.002_bib136","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0360-3016(01)01446-8","article-title":"Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB","volume":"50","author":"Russo","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.drup.2008.08.002_bib137","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1097-2765(01)00265-9","article-title":"Translational control is required for the unfolded protein response and in vivo glucose homeostasis","volume":"7","author":"Scheuner","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib138","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1534-5807(02)00203-4","article-title":"ER stress regulation of ATF6 localization by dissociation of BiP\/GRP78 binding and unmasking of Golgi localization signals","volume":"3","author":"Shen","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib139","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1128\/MCB.18.12.7499","article-title":"Identification and characterization of pancreatic eukaryotic initiation factor 2 alpha-subunit kinase, PEK, involved in translational control","volume":"18","author":"Shi","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.drup.2008.08.002_bib140","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-05-0068","article-title":"Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor\/insulin receptor substrate-1\/phosphatidylinositol 3-kinase cascade","volume":"4","author":"Shi","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2008.08.002_bib141","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10549-006-9232-x","article-title":"Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer","volume":"100","author":"Shi","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.drup.2008.08.002_bib142","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood-2007-11-120576","article-title":"Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1","volume":"111","author":"Shin","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.drup.2008.08.002_bib143","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/nm759","article-title":"PKB\/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization","volume":"8","author":"Shin","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2008.08.002_bib144","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1158\/0008-5472.CAN-06-1224","article-title":"Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression","volume":"67","author":"Shrader","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2141.2006.06132.x","article-title":"Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib","volume":"134","author":"Shringarpure","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drup.2008.08.002_bib146","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1073\/pnas.012485299","article-title":"Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway","volume":"99","author":"Talloczy","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2008.08.002_bib147","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ccr.2005.02.008","article-title":"Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy","volume":"7","author":"Tan","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib148","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1200\/JCO.2004.01.103","article-title":"Putting the rap on Akt","volume":"22","author":"Thompson","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2008.08.002_bib149","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1002\/j.1460-2075.1994.tb06878.x","article-title":"A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B","volume":"13","author":"Traenckner","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.drup.2008.08.002_bib150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0092-8674(00)80835-1","article-title":"Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation","volume":"101","author":"Travers","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib151","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/jnci\/95.12.845","article-title":"First proteasome inhibitor approved for multiple myeloma","volume":"95","author":"Twombly","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drup.2008.08.002_bib152","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature04782","article-title":"S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration","volume":"441","author":"Uehara","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.drup.2008.08.002_bib153","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1046\/j.1471-4159.2002.01211.x","article-title":"Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis","volume":"83","author":"Urushitani","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drup.2008.08.002_bib154","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.274.5288.787","article-title":"Suppression of TNF-alpha-induced apoptosis by NF-kappaB","volume":"274","author":"Van Antwerp","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.drup.2008.08.002_bib155","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2007.10.030","article-title":"IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis","volume":"131","author":"Varfolomeev","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.drup.2008.08.002_bib156","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1158\/1535-7163.MCT-05-0222","article-title":"Sensitization of DNA damage-induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3sigma and survivin","volume":"4","author":"Vaziri","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2008.08.002_bib157","first-page":"6316","article-title":"The proteasome as a target for cancer therapy","volume":"9","author":"Voorhees","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib158","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrm2147","article-title":"p53 in health and disease","volume":"8","author":"Vousden","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drup.2008.08.002_bib159","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1126\/science.274.5288.784","article-title":"TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB","volume":"274","author":"Wang","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.drup.2008.08.002_bib160","first-page":"119","article-title":"The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells","volume":"5","author":"Wang","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib161","doi-asserted-by":"crossref","first-page":"10698","DOI":"10.1074\/jbc.M800806200","article-title":"Constitutive production of NF-kappaB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2008.08.002_bib162","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.1059108","article-title":"Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death","volume":"292","author":"Wei","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.drup.2008.08.002_bib163","first-page":"835","article-title":"Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts","volume":"2","author":"Williams","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2008.08.002_bib164","first-page":"7338","article-title":"The proteasome inhibitor bortezomib stabilizes a novel active form of p53 in human LNCaP-Pro5 prostate cancer cells","volume":"63","author":"Williams","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib165","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1391.012","article-title":"Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress","volume":"1113","author":"Workman","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drup.2008.08.002_bib166","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1038\/sj.onc.1203891","article-title":"Aberrant p27Kip1 promoter methylation in malignant melanoma","volume":"19","author":"Worm","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2008.08.002_bib167","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1002\/j.1460-2075.1996.tb00845.x","article-title":"Inhibition of NF-kappaB\/Rel induces apoptosis of murine B cells","volume":"15","author":"Wu","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.drup.2008.08.002_bib168","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","article-title":"Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes","volume":"9","author":"Xiao","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.drup.2008.08.002_bib169","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.20072000","article-title":"Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene","volume":"205","author":"Yamashita","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drup.2008.08.002_bib170","first-page":"3419","article-title":"Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival","volume":"8","author":"Yang","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2008.08.002_bib171","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11481-007-9082-2","article-title":"Downregulation of parkin damages antioxidant defenses and enhances proteasome inhibition-induced toxicity in PC12 cells","volume":"2","author":"Yang","year":"2007","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.drup.2008.08.002_bib172","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canlet.2005.11.033","article-title":"Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells","volume":"243","author":"Yang","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2008.08.002_bib173","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1042\/BJ20080324","article-title":"Phosphorylation of eIF2alpha in response to 26S proteasome inhibition is mediated by the haem-regulated inhibitor (HRI) kinase","volume":"412","author":"Yerlikaya","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.drup.2008.08.002_bib174","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1158\/1535-7163.MCT-06-0235","article-title":"Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways","volume":"5","author":"Yu","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2008.08.002_bib175","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1182\/blood-2003-03-0737","article-title":"The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr\/Abl+ cells sensitive and resistant to STI571","volume":"102","author":"Yu","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.drup.2008.08.002_bib176","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4161\/cbt.2.6.573","article-title":"Differential apoptotic response to the proteasome inhibitor bortezomib [VELCADE, PS-341] in Bax-deficient and p21-deficient colon cancer cells","volume":"2","author":"Yu","year":"2003","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.drup.2008.08.002_bib177","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/MCB.22.11.3864-3874.2002","article-title":"The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas","volume":"22","author":"Zhang","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.drup.2008.08.002_bib178","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.drup.2007.08.002","article-title":"BH3 mimetics to improve cancer therapy: mechanisms and examples","volume":"10","author":"Zhang","year":"2007","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2008.08.002_bib179","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1038\/sj.onc.1208683","article-title":"Bik\/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors","volume":"24","author":"Zhu","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2008.08.002_bib180","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1101\/gad.12.7.982","article-title":"CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum","volume":"12","author":"Zinszner","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.drup.2008.08.002_bib181","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1158\/1078-0432.CCR-05-0503","article-title":"Vitamin C inactivates the proteasome inhibitor PS-341 in human cancer cells","volume":"12","author":"Zou","year":"2006","journal-title":"Clin. Cancer Res."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764608000472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764608000472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T02:24:27Z","timestamp":1684549467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764608000472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":181,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S1368764608000472"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2008.08.002","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}